Home・Aandelen Lijst・GE HealthCare Technologies

GE HealthCare Technologies

Gesloten

SectorGezondheidszorg

70.2 -0.07

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

68.98

Max

70.34

Belangrijke statistieken
By Trading Economics
Inkomsten	163M 574M
Verkoop	164M 5.3B
K/W Sectorgemiddelde	16.067 68.51
EPS	1.13
Dividendrendement	0.21
Winstmarge	10.84
Werknemers	54,000
EBITDA	52M 807M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+12.54% upside

Dividenden
By Acuity
Dividendrendement Sectorgemiddelde	0.21% 2.29%
Volgende Winsten	28 okt 2026
Volgende dividenddatum	14 aug 2026
Volgende Ex Dividend datum	23 okt 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	3.9B 32B
Vorige openingsprijs	70.27
Vorige sluitingsprijs	70.2

Nieuwssentiment

By Acuity

92%

10 / 340 Rangschikking in Healthcare

GE HealthCare Technologies Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

4 aug 2026, 23:41 UTC

Shares of GE Healthcare Technologies are trading higher in after-market hours, reflecting unusual activity and remaining above the 20-day moving average.

3 aug 2026, 23:01 UTC

Shares of GE Healthcare Technologies declined after-market, continuing a downward trend since Monday's close amid broader market conditions.

31 jul 2026, 23:16 UTC

News

Shares of GE Healthcare Technologies are lower in after-market trading following UBS's Neutral rating and a price target increase to $73.

30 jul 2026, 22:31 UTC

News

GE Healthcare Technologies reported Q2 revenue of $5.30 billion, but shares are trading lower after highlighting challenges in the Patient Care Solutions segment.

29 jul 2026, 23:21 UTC

GE Healthcare shares are lower in after-market hours, reflecting a decline after briefly recovering earlier in the session. No specific news was identified.

28 jul 2026, 23:41 UTC

GE Healthcare Technologies Inc. shares are higher in after-market trading, showing volatility with no specific news identified to explain the movement.

27 jul 2026, 23:16 UTC

GE Healthcare shares are trading higher in after-market hours, reflecting a modest increase since Monday's close amid positive sentiment in European markets.

24 jul 2026, 20:03 UTC

Event

News

GE Healthcare shares decline as CFO Jay Saccaro steps down amid preliminary Q2 results showing revenue growth to $5.295 billion.

23 jul 2026, 23:41 UTC

Event

News

GE Healthcare appointed George Newcomb as interim CFO and reported $5.30 billion in second-quarter revenue, with shares higher in after-market trading.

22 jul 2026, 23:31 UTC

GE Healthcare Technologies shares moved higher in after-market trading, despite earlier fluctuations. Broader market dynamics include rising crude oil prices amid U.S.-Iran tensions.

21 jul 2026, 23:46 UTC

GE Healthcare shares are higher in after-market hours amid positive market sentiment from recent earnings reports, though they remain below the 20-day moving average.

20 jul 2026, 16:31 UTC

News

GE Healthcare Technologies has launched MIM Anyware, enhancing remote access to its software portfolio. Shares are trading higher, breaking from a recent upward trend.

Peer Vergelijking

Prijswijziging

GE HealthCare Technologies Prognose

Koersdoel

By TipRanks

12.54% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 79.07 USD 12.54%

Hoogste 92 USD

Laagste 70 USD

Gebaseerd op 14 Wall Street-analisten die 12-maands prijsdoelen bieden voor GE HealthCare Technologies - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

14 ratings

Buy

Hold

Sell

Gebaseerd op 14 analisten die aandelenratings hebben gegeven aan GE HealthCare Technologies - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

10 / 340 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over GE HealthCare Technologies

GE HealthCare Technologies Inc. engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging segment offers molecular imaging, computed tomography (CT) scanning, magnetic resonance (MR) imaging, image-guided therapy, X-ray systems, and women's health products. The Ultrasound segment provides medical devices and solutions for screening, diagnosis, treatment, and monitoring of certain diseases in clinical areas, such as radiology and primary care, women's health, cardiovascular, and point of care and handheld ultrasound solutions, as well as surgical visualization and guidance products. The Patient Care Solutions segment provides medical devices, consumables, services, and digital solutions. Its portfolio includes patient monitoring solutions, anesthesia delivery and respiratory care products, electrocardiogram solutions, maternal infant care products, and consumables and services. The Pharmaceutical Diagnostics supplies diagnostic agents, including CT, angiography and X-ray, MR, single-photon emission computed tomography, positron emission tomography, and ultrasound to the radiology and nuclear medicine industry. The segment also provides contrast media pharmaceuticals that are administered to a patient prior to certain diagnostic scans to increase the visibility of tissues or structures during imaging exams; and molecular imaging agents or radiopharmaceuticals, which are molecular tracers labeled with radioisotopes. It has an AI collaboration with Mass General Brigham. The company was formerly known as GE Healthcare Holding LLC and changed its name to GE HealthCare Technologies Inc. in December 2022. The company was incorporated in 2022 and is headquartered in Chicago, Illinois.